Suchergebnisse - (Subject:"Adalimumab")

PubPharm (7.194)

31

Lupus-Like Syndrome in a Patient Treated With Adalimumab for Psoriasis

enthalten in: Journal of cutaneous medicine and surgery | 2024

von Lopes Castro, A. | Araujo, C.

32

Risk of serious infection associated with different classes of targeted therapies used in psoriatic arthritis : a nationwide cohort study from the French Health Insurance Database (SNDS)

enthalten in: RMD open | 2024

von Bastard, L. | Claudepierre, P. | Penso, L. | +2

33

Impact of filgotinib on pain control in the phase 3 FINCH studies

enthalten in: RMD open | 2024

von Taylor, P. | Kavanaugh, A. | Nash, P. | +10

ErratumIn: RMD Open. 2024 Apr 4;10(2):. - PMID 38580354

34

Implications of Immunogenicity Testing for Therapeutic Monoclonal Antibodies : A Quantitative Pharmacology Framework

enthalten in: The AAPS journal | 2024

von Williams, J. | Liao, K. | Yin, D. | +1

35

Persistence and safety of anti-TNF biosimilars versus originators in immune-mediated inflammatory diseases : an observational study on the French National Health Data System

enthalten in: RMD open | 2024

von Jourdain, H. | Hoisnard, L. | Sbidian, E. | +1

36

Forty-Eight-Month Monitoring of Disease Activity in Patients with Long-Standing Rheumatoid Arthritis Treated with TNF-α Inhibitors : Time for Clinical Outcome Prediction and Biosimilar vs Biologic Originator Performance

enthalten in: Clinical drug investigation | 2024

von Colina, M. | Khodeir, M. | Rimondini, R. | +4

37

Effectiveness and safety of adalimumab compared with leflunomide in patients with Takayasu arteritis : a retrospective cohort study

enthalten in: RMD open | 2024

von Peron Filho, F. | Moreira, A. | Janes, A. | +1

38

Efficacy and safety of adalimumab in pediatric patients with Crohn's disease : A systematic review and meta-analysis

enthalten in: European journal of clinical pharmacology | 2024

von Chen, B. | Zou, Z. | Zhang, X. | +2

39

Prospective Observational Evaluation of the Time-Dependency of Adalimumab Immunogenicity and Drug Concentration in Ulcerative Colitis Patients : the POETIC II Study

enthalten in: Journal of Crohn's & colitis | 2024

von Harnik, S. | Abitbol, C. | Haj Natour, O. | +15

CommentIn: J Crohns Colitis. 2023 Oct 17;:. - PMID 37847799

40

Adalimumab : A 'Maillon Faible' in the Treatment of Ulcerative Colitis?

enthalten in: Journal of Crohn's & colitis | 2024

von Roblin, X. | Paul, S.

CommentOn: J Crohns Colitis. 2024 Mar 1;18(3):341-348. - PMID 37691574